Two Efforts To Tackle Medical Marijuana Issues

The National Institutes of Health's "Workshop on the Medical Utility of Marijuana," held February 19 and 20, served as a forum for researchers to present data on the therapeutic uses of the drug to an eight-member panel of scientists. The panel's recommendations may help determine future funding of studies to assess marijuana's possible healing powers. Panel members, who represent a broad spectrum of medical researchers, are: William T. Beaver, a professor of pharmacology and anesthesia at Geo

Written byPeter Gwynne
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The National Institutes of Health's "Workshop on the Medical Utility of Marijuana," held February 19 and 20, served as a forum for researchers to present data on the therapeutic uses of the drug to an eight-member panel of scientists. The panel's recommendations may help determine future funding of studies to assess marijuana's possible healing powers.

Panel members, who represent a broad spectrum of medical researchers, are:

William T. Beaver, a professor of pharmacology and anesthesia at Georgetown University School of Medicine (chairman); Julie E. Buring, an associate professor of epidemiology at Harvard Medical School; Avram Goldstein, a professor, emeritus, of pharmacology at Stanford University; Kenneth Johnson, a professor of neurology at University of Maryland Hospital; Mark G. Kris, an attending physician at Memorial Sloan-Kettering Cancer Center; Kathi Mooney, a professor of parent-child and adult nursing at University of Utah College of Nursing; Paul Palmberg, a professor of ophthalmology at University ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies